Cimilactone A

CAS No. 468733-06-4

Cimilactone A( ——— )

Catalog No. M39122 CAS No. 468733-06-4

Cimilactone A is a cycloartane-type triterpene glycoside. Cimilactone A can be isolated from the rhizomes of Cimicifuga foetida.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cimilactone A
  • Note
    Research use only, not for human use.
  • Brief Description
    Cimilactone A is a cycloartane-type triterpene glycoside. Cimilactone A can be isolated from the rhizomes of Cimicifuga foetida.
  • Description
    Cimilactone A shows significant anticomplement activity (IC(50)= 28.6 microm).
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    468733-06-4
  • Formula Weight
    590.754
  • Molecular Formula
    C33H50O9
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li-Rong Sun, et al. Cimicifoetisides A and B, two cytotoxic cycloartane triterpenoid glycosides from the rhizomes of Cimicifuga foetida, inhibit proliferation of cancer cells. Beilstein J Org Chem. 2007 Jan 31;3:3. ?
molnova catalog
related products
  • Tectorigenin 7-?O-?X...

    Tectorigenin 7-O-xylosylglucoside is a natural product.

  • Concizumab

    Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site.

  • D-Proline

    D-proline is an isomer of the naturally occurring amino acid L-Proline. D-amino acids have been found in relatively high abundance in human plasma and saliva. These amino acids may be of bacterial origin but there is also evidence that they are endogenously produced through amino acid racemase activity.